These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31292250)

  • 41. Chimeric
    Olmedillas E; Cano O; Martínez I; Luque D; Terrón MC; McLellan JS; Melero JA; Más V
    EMBO Mol Med; 2018 Feb; 10(2):175-187. PubMed ID: 29217660
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigenic Site-Specific Competitive Antibody Responses to the Fusion Protein of Respiratory Syncytial Virus Were Associated With Viral Clearance in Hematopoietic Cell Transplantation Adults.
    Ye X; Iwuchukwu OP; Avadhanula V; Aideyan LO; McBride TJ; Ferlic-Stark LL; Patel KD; Piedra FA; Shah DP; Chemaly RF; Piedra PA
    Front Immunol; 2019; 10():706. PubMed ID: 30984206
    [No Abstract]   [Full Text] [Related]  

  • 43. A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.
    Ballegeer M; van Scherpenzeel RC; Delgado T; Iglesias-Caballero M; García Barreno B; Pandey S; Rush SA; Kolkman JA; Mas V; McLellan JS; Saelens X
    mBio; 2024 Jan; 15(1):e0212223. PubMed ID: 38117059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of pre- and post-fusion Human metapneumovirus F proteins as subunit vaccine candidates in mice.
    Pilaev M; Shen Y; Carbonneau J; Venable MC; Rhéaume C; Lavigne S; Couture C; Guarné A; Hamelin MÈ; Boivin G
    Vaccine; 2020 Feb; 38(9):2122-2127. PubMed ID: 32007293
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitope.
    McCool RS; Musayev M; Bush SM; Derrien-Colemyn A; Acreman CM; Wrapp D; Ruckwardt TJ; Graham BS; Mascola JR; McLellan JS
    J Virol; 2023 Oct; 97(10):e0092923. PubMed ID: 37737588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Roles of the putative integrin-binding motif of the human metapneumovirus fusion (f) protein in cell-cell fusion, viral infectivity, and pathogenesis.
    Wei Y; Zhang Y; Cai H; Mirza AM; Iorio RM; Peeples ME; Niewiesk S; Li J
    J Virol; 2014 Apr; 88(8):4338-52. PubMed ID: 24478423
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serological cross-reactivity of members of the Metapneumovirus genus.
    Alvarez R; Jones LP; Seal BS; Kapczynski DR; Tripp RA
    Virus Res; 2004 Sep; 105(1):67-73. PubMed ID: 15325082
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.
    Russell CJ; Jones BG; Sealy RE; Surman SL; Mason JN; Hayden RT; Tripp RA; Takimoto T; Hurwitz JL
    Virology; 2017 Sep; 509():60-66. PubMed ID: 28605636
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structural basis for respiratory syncytial virus and human metapneumovirus neutralization.
    Miller RJ; Mousa JJ
    Curr Opin Virol; 2023 Aug; 61():101337. PubMed ID: 37544710
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Development and properties of neutralizing monoclonal antibodies for fusion protein of respiratory syncytial virus.].
    Kushch AA; Klimova RR; Fedorova NE; Masalova OV; Niconova AA; Lesnova EI; Momotyuk ED; Demidova NA; Samartseva TG; Zverev VV
    Vopr Virusol; 2019; 64(2):90-96. PubMed ID: 31412175
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge.
    Gilbert BE; Patel N; Lu H; Liu Y; Guebre-Xabier M; Piedra PA; Glenn G; Ellingsworth L; Smith G
    Vaccine; 2018 Dec; 36(52):8069-8078. PubMed ID: 30389195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.
    Gilman MS; Moin SM; Mas V; Chen M; Patel NK; Kramer K; Zhu Q; Kabeche SC; Kumar A; Palomo C; Beaumont T; Baxa U; Ulbrandt ND; Melero JA; Graham BS; McLellan JS
    PLoS Pathog; 2015 Jul; 11(7):e1005035. PubMed ID: 26161532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Conformational Flexibility in Respiratory Syncytial Virus G Neutralizing Epitopes.
    Fedechkin SO; George NL; Nuñez Castrejon AM; Dillen JR; Kauvar LM; DuBois RM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852779
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus.
    Rush SA; Brar G; Hsieh CL; Chautard E; Rainho-Tomko JN; Slade CD; Bricault CA; Kume A; Kearns J; Groppo R; Mundle ST; Zhang L; Casimiro D; Fu TM; DiNapoli JM; McLellan JS
    Cell Rep; 2022 Sep; 40(12):111399. PubMed ID: 36130517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal antibody based in vitro potency assay as a predictor of antigenic integrity and in vivo immunogenicity of a Respiratory Syncytial Virus post-fusion F-protein based vaccine.
    Djagbare MD; Yu L; Parupudi A; Sun J; Coughlin ML; Rush BS; Sanyal G
    Vaccine; 2018 Mar; 36(12):1673-1680. PubMed ID: 29456016
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.
    Fong RH; Banik SS; Mattia K; Barnes T; Tucker D; Liss N; Lu K; Selvarajah S; Srinivasan S; Mabila M; Miller A; Muench MO; Michault A; Rucker JB; Paes C; Simmons G; Kahle KM; Doranz BJ
    J Virol; 2014 Dec; 88(24):14364-79. PubMed ID: 25275138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.
    Cairns TM; Fontana J; Huang ZY; Whitbeck JC; Atanasiu D; Rao S; Shelly SS; Lou H; Ponce de Leon M; Steven AC; Eisenberg RJ; Cohen GH
    J Virol; 2014 Mar; 88(5):2677-89. PubMed ID: 24352457
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a neutralizing epitope within antigenic domain 5 of glycoprotein B of human cytomegalovirus.
    Wiegers AK; Sticht H; Winkler TH; Britt WJ; Mach M
    J Virol; 2015 Jan; 89(1):361-72. PubMed ID: 25320309
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.
    Chapman NS; Zhao H; Kose N; Westover JB; Kalveram B; Bombardi R; Rodriguez J; Sutton R; Genualdi J; LaBeaud AD; Mutuku FM; Pittman PR; Freiberg AN; Gowen BB; Fremont DH; Crowe JE
    Proc Natl Acad Sci U S A; 2021 Apr; 118(14):. PubMed ID: 33782133
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats.
    Cseke G; Wright DW; Tollefson SJ; Johnson JE; Crowe JE; Williams JV
    J Virol; 2007 Jan; 81(2):698-707. PubMed ID: 17050599
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.